11.9 C
New York
Wednesday, March 22, 2023

HCA Healthcare Inc. (NYSE: HCA): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for HCA Healthcare Inc. (HCA) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$4.00, or -1.62%, to $243.07. The HCA Healthcare Inc. has recorded 17,500 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that HCA Healthcare Named as One of the 2023 World’s Most Ethical Companies®.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Stocks Info

HCA belongs to the Healthcare sector of the NYSE while operating in the Medical Care Facilities industry. At the end of the last regular session, the stock closed at $247.07 and fluctuated between $249.96 as its day high and $241.33 as its day low. The current market capitalization of HCA Healthcare Inc. is $69.97B. A total of 1.06 million shares were traded on the day, compared to an average of 1.25M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, HCA has seen 35 BUY and 45 SELL insider trades, representing the acquisition of 435,231 and the disposition of 273,352 shares. Over the last 12 months, there were 54 BUYs and 64 SELLs from insiders. Insiders purchased 605,676 shares during that period but sold 437,527.

In the most recent transaction, Whalen Kathleen M sold 1,734 shares of HCA for 263.61 per share on Feb 17. After the transaction, the SVP & Chief Ethics Officer now owns 9,962 company shares. In a previous transaction on Feb 07, Berres Jennifer sold 4,000 shares at 255.23 per share. HCA shares that SVP & Chief Human Res. Officer owns now total 7,392.

Among the insiders who sold shares, RUTHERFORD BILL B disposed of 30,000 shares on Feb 03 at a per-share price of $258.19. This resulted in the CFO and EVP holding 81,632 shares of HCA after the transaction. In another insider transaction, Reiner Deborah M sold 7,941 shares at $257.61 per share on Feb 03. Company shares held by the SVP – Mktg. & Communications now total 0.


Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. HCA Healthcare Inc. pays an annual dividend of $2.40, resulting in a dividend yield of 0.97%, and it has a price to earnings (P/E) ratio of 12.84. HCA’s most recent ex-dividend date was 3/16/2023 when it declared a $0.60 quarterly dividend that was paid in cash on 3/31/2023. Previously, the company paid the dividend on 12/28/2022 with an ex-dividend date of 12/13/2022. The HCA stock dividend was $0.56 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for HCA in the last 3 months, the mean price target is $282.41 with high estimates of $310.00 and low estimates of $243.00. In terms of 52-week highs and lows, HCA has a high of $279.02 and a low of $164.47.

As of this writing, HCA has an earnings estimate of $4.01 per share for the current quarter. EPS was calculated based on a consensus of 17 estimates, with a high estimate of $4.42 per share and a lower estimate of $3.24. The company reported an EPS of $3.93 in the last quarter, which was 1.30% higher than expectations of $3.88.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 25 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HCA is Sell with a score of 4.58. A total of 17 analysts rated the stock as Buy while 2 rated it as Overweight while 6 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles